Cargando…
Coenzyme Q10 and Silymarin Reduce CCl(4)-Induced Oxidative Stress and Liver and Kidney Injury in Ovariectomized Rats—Implications for Protective Therapy in Chronic Liver and Kidney Diseases
Oxidative stress is one of the key factors in the pathophysiology of liver disease. The present study aimed to evaluate the potential impact of two antioxidants, namely coenzyme Q10 (CoQ10) and silymarin, on carbon tetrachloride (CCl(4))-induced oxidative stress and hepatic damage in ovariectomized...
Autores principales: | Lamia, Samanta Sifat, Emran, Tushar, Rikta, Jubaida Khatun, Chowdhury, Nowreen Islam, Sarker, Manoneeta, Jain, Preeti, Islam, Tabinda, Gias, Zarin Tasnim, Shill, Manik Chandra, Reza, Hasan Mahmud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830449/ https://www.ncbi.nlm.nih.gov/pubmed/35366269 http://dx.doi.org/10.3390/pathophysiology28010005 |
Ejemplares similares
-
Protective effect of silymarin on tacrolimus-induced kidney and liver toxicity
por: Terzi, Funda, et al.
Publicado: (2022) -
Beyond the liver protective efficacy of silymarin; bright renoprotective effect on diabetic kidney disease
por: Amiri, Masoud, et al.
Publicado: (2014) -
Investigating the impact of silymarin on liver oxidative injury
por: Jamalian, Mohammad, et al.
Publicado: (2020) -
Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD Patients
por: Curcio, Annalisa, et al.
Publicado: (2020) -
Co-Administration of Silymarin and Deferoxamine against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model
por: Navidi-Shishaone, Mitra, et al.
Publicado: (2014)